 | • レポートコード：MRC309Z8048 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の低分子タンパク質分解剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の低分子タンパク質分解剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 低分子タンパク質分解剤の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 低分子タンパク質分解剤市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・分子ゲル分解装置、タンパク質分解ターゲットキメラ 用途別セグメント ・がん治療、神経変性疾患治療、その他 主要な市場プレーヤー ・BMS、Monte Rosa Therapeutics、Nurix、Novartis、Eisai、Boehringer Ingelheim、Proxygen、Merck Sharp & Dohme、Arvinas、Amgen、Shanghai Meizhi Pharmaceutical、Fendi Technology、Five-Membered Creatures、Gluetacs Therapeutics、Hengrui Medicine、Degron Therapeutics 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、低分子タンパク質分解剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な低分子タンパク質分解剤メーカーの企業概要、2019年～2022年までの低分子タンパク質分解剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な低分子タンパク質分解剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別低分子タンパク質分解剤の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの低分子タンパク質分解剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での低分子タンパク質分解剤市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および低分子タンパク質分解剤の産業チェーンを掲載しています。 ・第14、15章では、低分子タンパク質分解剤の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 低分子タンパク質分解剤の概要 - 種類別分析（2018年vs2022年vs2029年）：分子ゲル分解装置、タンパク質分解ターゲットキメラ - 用途別分析（2018年vs2022年vs2029年）：がん治療、神経変性疾患治療、その他 - 世界の低分子タンパク質分解剤市場規模・予測 - 世界の低分子タンパク質分解剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - BMS、Monte Rosa Therapeutics、Nurix、Novartis、Eisai、Boehringer Ingelheim、Proxygen、Merck Sharp & Dohme、Arvinas、Amgen、Shanghai Meizhi Pharmaceutical、Fendi Technology、Five-Membered Creatures、Gluetacs Therapeutics、Hengrui Medicine、Degron Therapeutics ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：分子ゲル分解装置、タンパク質分解ターゲットキメラ ・用途別分析2018年-2029年：がん治療、神経変性疾患治療、その他 ・低分子タンパク質分解剤の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・低分子タンパク質分解剤のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・低分子タンパク質分解剤のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・低分子タンパク質分解剤の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・低分子タンパク質分解剤の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Small Molecule Protein Degradation Agent market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Small Molecule Protein Degradation Agent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Small Molecule Protein Degradation Agent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Small Molecule Protein Degradation Agent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Small Molecule Protein Degradation Agent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Small Molecule Protein Degradation Agent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Small Molecule Protein Degradation Agent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Small Molecule Protein Degradation Agent market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BMS, Monte Rosa Therapeutics, Nurix, Novartis and Eisai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Small Molecule Protein Degradation Agent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Molecular Gel Degrader
Protein Degradation Targets Chimeras
Market segment by Application
Oncology Treatment
Cancer Treatment
Treatment Of Neurodegenerative Diseases
Other
Major players covered
BMS
Monte Rosa Therapeutics
Nurix
Novartis
Eisai
Boehringer Ingelheim
Proxygen
Merck Sharp & Dohme
Arvinas
Amgen
Shanghai Meizhi Pharmaceutical
Fendi Technology
Five-Membered Creatures
Gluetacs Therapeutics
Hengrui Medicine
Degron Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Small Molecule Protein Degradation Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Small Molecule Protein Degradation Agent, with price, sales, revenue and global market share of Small Molecule Protein Degradation Agent from 2018 to 2023.
Chapter 3, the Small Molecule Protein Degradation Agent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Small Molecule Protein Degradation Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Small Molecule Protein Degradation Agent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Small Molecule Protein Degradation Agent.
Chapter 14 and 15, to describe Small Molecule Protein Degradation Agent sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Small Molecule Protein Degradation Agent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Small Molecule Protein Degradation Agent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Molecular Gel Degrader
1.3.3 Protein Degradation Targets Chimeras
1.4 Market Analysis by Application
1.4.1 Overview: Global Small Molecule Protein Degradation Agent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Oncology Treatment
1.4.3 Cancer Treatment
1.4.4 Treatment Of Neurodegenerative Diseases
1.4.5 Other
1.5 Global Small Molecule Protein Degradation Agent Market Size & Forecast
1.5.1 Global Small Molecule Protein Degradation Agent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Small Molecule Protein Degradation Agent Sales Quantity (2018-2029)
1.5.3 Global Small Molecule Protein Degradation Agent Average Price (2018-2029)
2 Manufacturers Profiles
2.1 BMS
2.1.1 BMS Details
2.1.2 BMS Major Business
2.1.3 BMS Small Molecule Protein Degradation Agent Product and Services
2.1.4 BMS Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BMS Recent Developments/Updates
2.2 Monte Rosa Therapeutics
2.2.1 Monte Rosa Therapeutics Details
2.2.2 Monte Rosa Therapeutics Major Business
2.2.3 Monte Rosa Therapeutics Small Molecule Protein Degradation Agent Product and Services
2.2.4 Monte Rosa Therapeutics Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Monte Rosa Therapeutics Recent Developments/Updates
2.3 Nurix
2.3.1 Nurix Details
2.3.2 Nurix Major Business
2.3.3 Nurix Small Molecule Protein Degradation Agent Product and Services
2.3.4 Nurix Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Nurix Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Small Molecule Protein Degradation Agent Product and Services
2.4.4 Novartis Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments/Updates
2.5 Eisai
2.5.1 Eisai Details
2.5.2 Eisai Major Business
2.5.3 Eisai Small Molecule Protein Degradation Agent Product and Services
2.5.4 Eisai Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eisai Recent Developments/Updates
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Small Molecule Protein Degradation Agent Product and Services
2.6.4 Boehringer Ingelheim Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Boehringer Ingelheim Recent Developments/Updates
2.7 Proxygen
2.7.1 Proxygen Details
2.7.2 Proxygen Major Business
2.7.3 Proxygen Small Molecule Protein Degradation Agent Product and Services
2.7.4 Proxygen Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Proxygen Recent Developments/Updates
2.8 Merck Sharp & Dohme
2.8.1 Merck Sharp & Dohme Details
2.8.2 Merck Sharp & Dohme Major Business
2.8.3 Merck Sharp & Dohme Small Molecule Protein Degradation Agent Product and Services
2.8.4 Merck Sharp & Dohme Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merck Sharp & Dohme Recent Developments/Updates
2.9 Arvinas
2.9.1 Arvinas Details
2.9.2 Arvinas Major Business
2.9.3 Arvinas Small Molecule Protein Degradation Agent Product and Services
2.9.4 Arvinas Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Arvinas Recent Developments/Updates
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Small Molecule Protein Degradation Agent Product and Services
2.10.4 Amgen Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Amgen Recent Developments/Updates
2.11 Shanghai Meizhi Pharmaceutical
2.11.1 Shanghai Meizhi Pharmaceutical Details
2.11.2 Shanghai Meizhi Pharmaceutical Major Business
2.11.3 Shanghai Meizhi Pharmaceutical Small Molecule Protein Degradation Agent Product and Services
2.11.4 Shanghai Meizhi Pharmaceutical Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Meizhi Pharmaceutical Recent Developments/Updates
2.12 Fendi Technology
2.12.1 Fendi Technology Details
2.12.2 Fendi Technology Major Business
2.12.3 Fendi Technology Small Molecule Protein Degradation Agent Product and Services
2.12.4 Fendi Technology Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Fendi Technology Recent Developments/Updates
2.13 Five-Membered Creatures
2.13.1 Five-Membered Creatures Details
2.13.2 Five-Membered Creatures Major Business
2.13.3 Five-Membered Creatures Small Molecule Protein Degradation Agent Product and Services
2.13.4 Five-Membered Creatures Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Five-Membered Creatures Recent Developments/Updates
2.14 Gluetacs Therapeutics
2.14.1 Gluetacs Therapeutics Details
2.14.2 Gluetacs Therapeutics Major Business
2.14.3 Gluetacs Therapeutics Small Molecule Protein Degradation Agent Product and Services
2.14.4 Gluetacs Therapeutics Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Gluetacs Therapeutics Recent Developments/Updates
2.15 Hengrui Medicine
2.15.1 Hengrui Medicine Details
2.15.2 Hengrui Medicine Major Business
2.15.3 Hengrui Medicine Small Molecule Protein Degradation Agent Product and Services
2.15.4 Hengrui Medicine Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Hengrui Medicine Recent Developments/Updates
2.16 Degron Therapeutics
2.16.1 Degron Therapeutics Details
2.16.2 Degron Therapeutics Major Business
2.16.3 Degron Therapeutics Small Molecule Protein Degradation Agent Product and Services
2.16.4 Degron Therapeutics Small Molecule Protein Degradation Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Degron Therapeutics Recent Developments/Updates
3 Competitive Environment: Small Molecule Protein Degradation Agent by Manufacturer
3.1 Global Small Molecule Protein Degradation Agent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Small Molecule Protein Degradation Agent Revenue by Manufacturer (2018-2023)
3.3 Global Small Molecule Protein Degradation Agent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Small Molecule Protein Degradation Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Small Molecule Protein Degradation Agent Manufacturer Market Share in 2022
3.4.2 Top 6 Small Molecule Protein Degradation Agent Manufacturer Market Share in 2022
3.5 Small Molecule Protein Degradation Agent Market: Overall Company Footprint Analysis
3.5.1 Small Molecule Protein Degradation Agent Market: Region Footprint
3.5.2 Small Molecule Protein Degradation Agent Market: Company Product Type Footprint
3.5.3 Small Molecule Protein Degradation Agent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Small Molecule Protein Degradation Agent Market Size by Region
4.1.1 Global Small Molecule Protein Degradation Agent Sales Quantity by Region (2018-2029)
4.1.2 Global Small Molecule Protein Degradation Agent Consumption Value by Region (2018-2029)
4.1.3 Global Small Molecule Protein Degradation Agent Average Price by Region (2018-2029)
4.2 North America Small Molecule Protein Degradation Agent Consumption Value (2018-2029)
4.3 Europe Small Molecule Protein Degradation Agent Consumption Value (2018-2029)
4.4 Asia-Pacific Small Molecule Protein Degradation Agent Consumption Value (2018-2029)
4.5 South America Small Molecule Protein Degradation Agent Consumption Value (2018-2029)
4.6 Middle East and Africa Small Molecule Protein Degradation Agent Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Small Molecule Protein Degradation Agent Sales Quantity by Type (2018-2029)
5.2 Global Small Molecule Protein Degradation Agent Consumption Value by Type (2018-2029)
5.3 Global Small Molecule Protein Degradation Agent Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Small Molecule Protein Degradation Agent Sales Quantity by Application (2018-2029)
6.2 Global Small Molecule Protein Degradation Agent Consumption Value by Application (2018-2029)
6.3 Global Small Molecule Protein Degradation Agent Average Price by Application (2018-2029)
7 North America
7.1 North America Small Molecule Protein Degradation Agent Sales Quantity by Type (2018-2029)
7.2 North America Small Molecule Protein Degradation Agent Sales Quantity by Application (2018-2029)
7.3 North America Small Molecule Protein Degradation Agent Market Size by Country
7.3.1 North America Small Molecule Protein Degradation Agent Sales Quantity by Country (2018-2029)
7.3.2 North America Small Molecule Protein Degradation Agent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Small Molecule Protein Degradation Agent Sales Quantity by Type (2018-2029)
8.2 Europe Small Molecule Protein Degradation Agent Sales Quantity by Application (2018-2029)
8.3 Europe Small Molecule Protein Degradation Agent Market Size by Country
8.3.1 Europe Small Molecule Protein Degradation Agent Sales Quantity by Country (2018-2029)
8.3.2 Europe Small Molecule Protein Degradation Agent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Small Molecule Protein Degradation Agent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Small Molecule Protein Degradation Agent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Small Molecule Protein Degradation Agent Market Size by Region
9.3.1 Asia-Pacific Small Molecule Protein Degradation Agent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Small Molecule Protein Degradation Agent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Small Molecule Protein Degradation Agent Sales Quantity by Type (2018-2029)
10.2 South America Small Molecule Protein Degradation Agent Sales Quantity by Application (2018-2029)
10.3 South America Small Molecule Protein Degradation Agent Market Size by Country
10.3.1 South America Small Molecule Protein Degradation Agent Sales Quantity by Country (2018-2029)
10.3.2 South America Small Molecule Protein Degradation Agent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Small Molecule Protein Degradation Agent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Small Molecule Protein Degradation Agent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Small Molecule Protein Degradation Agent Market Size by Country
11.3.1 Middle East & Africa Small Molecule Protein Degradation Agent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Small Molecule Protein Degradation Agent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Small Molecule Protein Degradation Agent Market Drivers
12.2 Small Molecule Protein Degradation Agent Market Restraints
12.3 Small Molecule Protein Degradation Agent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Small Molecule Protein Degradation Agent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Small Molecule Protein Degradation Agent
13.3 Small Molecule Protein Degradation Agent Production Process
13.4 Small Molecule Protein Degradation Agent Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Small Molecule Protein Degradation Agent Typical Distributors
14.3 Small Molecule Protein Degradation Agent Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer